Skip to content
Search

Latest Stories

Flu jab uptake among over 65s hits record high

Despite the complexities of rolling out the largest national NHS flu immunisation programme during a Covid-19 winter, community pharmacies, GPs and others have vaccinated a record 80.3 per cent of those aged 65 years and over in England against flu so far this year.

This is the highest uptake ever achieved for this group and is just under 10 per cent higher than this time last year, exceeding the World Health Organization uptake ambition of 75 per cent, Public Health England's latest data has revealed.


Uptake in two- and three-year-old children is also the highest ever recorded, at 54 per cent and 56.5 per cent respectively.

Flu vaccine uptake rates are also higher than the same period during the last winter season for all other eligible groups. This includes an uptake rate of 51.5 per cent in clinical at-risk groups aged under 65 years, which is the highest achieved figure in the last seven seasons.

Pharmacy minister Jo Churchill said: “It is fantastic to see that despite the unique challenges of this winter, more over 65s than ever before have had their flu vaccination and that there is such high uptake across the eligible groups.

“Every year health and care staff do an incredible job rolling out the flu vaccine, and this year the Covid-19 vaccine too, to protect us all.”

As of December 1, all 50 to 64 year olds became eligible for the flu vaccine and 26.1 per cent of those in the age group have taken up the offer so far.

Meanwhile, NHS England has achieved some of the highest flu vaccine uptake rates in Europe for healthcare workers, with an uptake of 74.3 per cent by the end of the season in 2019 to 2020. By the end of November 2020, 70.5 per cent of frontline healthcare workers had already been vaccinated, compared to 61.5 per cent at the same period last year.

This means more than 120,000 additional healthcare workers had been vaccinated than the same time last year.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less